217 related articles for article (PubMed ID: 25566185)
1. The podocyte power-plant disaster and its contribution to glomerulopathy.
Müller-Deile J; Schiffer M
Front Endocrinol (Lausanne); 2014; 5():209. PubMed ID: 25566185
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis.
Li Y; Fan J; Zhu W; Niu Y; Wu M; Zhang A
Kidney Dis (Basel); 2023 Aug; 9(4):254-264. PubMed ID: 37900001
[TBL] [Abstract][Full Text] [Related]
3. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
[TBL] [Abstract][Full Text] [Related]
4. The complicated role of mitochondria in the podocyte.
Gujarati NA; Vasquez JM; Bogenhagen DF; Mallipattu SK
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F955-F965. PubMed ID: 33073585
[TBL] [Abstract][Full Text] [Related]
5. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
6. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
8. Podocyte energy metabolism and glomerular diseases.
Imasawa T; Rossignol R
Int J Biochem Cell Biol; 2013 Sep; 45(9):2109-18. PubMed ID: 23806869
[TBL] [Abstract][Full Text] [Related]
9. Podocyte lesions in patients with obesity-related glomerulopathy.
Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
[TBL] [Abstract][Full Text] [Related]
10. Dysfunction of the PGC-1α-mitochondria axis confers adriamycin-induced podocyte injury.
Zhu C; Xuan X; Che R; Ding G; Zhao M; Bai M; Jia Z; Huang S; Zhang A
Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1410-7. PubMed ID: 24808537
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease: focal segmental glomerulosclerosis.
Meyrier A
Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
[TBL] [Abstract][Full Text] [Related]
12. Modulation of podocyte phenotype in collapsing glomerulopathies.
Barisoni L; Kopp JB
Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
[TBL] [Abstract][Full Text] [Related]
13. Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).
D'Agati VD
Kidney Int; 2008 Feb; 73(4):399-406. PubMed ID: 17989648
[TBL] [Abstract][Full Text] [Related]
14. E pluribus unum: The riddle of focal segmental glomerulosclerosis.
Meyrier A
Semin Nephrol; 2003 Mar; 23(2):135-40. PubMed ID: 12704573
[TBL] [Abstract][Full Text] [Related]
15. Podocyte and Parietal Epithelial Cell Interactions in Health and Disease.
Al Hussain T; Al Mana H; Hussein MH; Akhtar M
Adv Anat Pathol; 2017 Jan; 24(1):24-34. PubMed ID: 27677082
[TBL] [Abstract][Full Text] [Related]
16. New players in the pathogenesis of focal segmental glomerulosclerosis.
Schell C; Huber TB
Nephrol Dial Transplant; 2012 Sep; 27(9):3406-12. PubMed ID: 22767631
[TBL] [Abstract][Full Text] [Related]
17. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
18. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
[TBL] [Abstract][Full Text] [Related]
19. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
[TBL] [Abstract][Full Text] [Related]
20. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
